Accessibility Menu
 
Endra Life Sciences logo

Endra Life Sciences

(NASDAQ) NDRA

Current Price$3.26
Market Cap$4.02M
Since IPO (2017)-100%
5 Year-100%
1 Year-14%
1 Month+0%

Endra Life Sciences Financials at a Glance

Market Cap

$4.02M

Revenue (TTM)

$0.00

Net Income (TTM)

$8.01M

EPS (TTM)

$-13.39

P/E Ratio

-0.26

Dividend

$0.00

Beta (Volatility)

1.13 (Average)

Price

$3.26

Volume

343

Open

$3.22

Previous Close

$3.26

Daily Range

$3.22 - $3.26

52-Week Range

$2.90 - $11.96

NDRA News

No articles available.

NDRA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Endra Life Sciences

Industry

Healthcare Equipment and Supplies

Employees

21

CEO

Alexander Y. Tokman

Headquarters

Ann Arbor, MI 48105-1570, US

NDRA Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-236%

Return on Capital

-7%

Return on Assets

-4%

Earnings Yield

-3.85%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.02M

Shares Outstanding

1.17M

Volume

343

Short Interest

0.00%

Avg. Volume

106.49K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$10.82M

EBITDA

$10.77M

Operating Cash Flow

$7.40M

Capital Expenditure

$16.00K

Free Cash Flow

$7.42M

Cash & ST Invst.

$3.23M

Total Debt

$584.42K

Endra Life Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$39.39K

N/A

Gross Margin

0.00%

N/A

Market Cap

$4.02M

N/A

Market Cap/Employee

$191.63K

N/A

Employees

21

N/A

Net Income

$1.60M

+32.2%

EBITDA

$1.56M

-7.0%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$268.71K

-93.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$396.54K

+695.9%

Short Term Debt

$128.79K

-67.4%

Return on Assets

-4.08%

N/A

Return on Invested Capital

-7.25%

N/A

Free Cash Flow

$1.16M

+29.8%

Operating Cash Flow

$1.16M

+29.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HSCSHeartSciences Inc.
$2.55-0.78%
BBLGBone Biologics Corporation
$1.16+0.00%
BGMSBio Green Med Solution, Inc.
$0.94+2.17%
NAOVNanoVibronix, Inc.
$1.90+1.06%

Trending Stocks

Symbol / CompanyPricePrice Chg
CMCSAComcast
$29.02+0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
RITMRithm Capital
$8.77-0.03%

Questions About NDRA

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.